Literature DB >> 2488086

Does digitalis work in chronic heart failure? The end of a 200-year-old controversy.

M Packer1.   

Abstract

Controlled trials using modern methods of assessment in well-defined groups of patients have now convincingly demonstrated that digitalis is an effective and well-tolerated drug in patients with chronic heart failure who have left ventricular systolic dysfunction. These encouraging findings concerning digitalis, however, should not be construed to suggest that the drug should be used alone in the treatment of heart failure. Digitalis cannot adequately control the fluid retention seen in most patients with chronic heart failure; diuretics should be added to maintain sodium balance. Digitalis has not been shown to prolong life in chronic heart failure; converting-enzyme inhibitors should be added to reduce morbidity and mortality. All three drugs should be used together in the management of patients with this disorder.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2488086     DOI: 10.1007/bf00133202

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  27 in total

1.  Effects of captopril on survival in patients with heart failure.

Authors:  T J Newman; C S Maskin; L G Dennick; J H Meyer; B G Hallows; W H Cooper
Journal:  Am J Med       Date:  1988-03-11       Impact factor: 4.965

2.  Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. The Captopril-Digoxin Multicenter Research Group.

Authors: 
Journal:  JAMA       Date:  1988 Jan 22-29       Impact factor: 56.272

3.  Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure.

Authors:  M Packer; N Medina; M Yushak; J Meller
Journal:  Circulation       Date:  1983-10       Impact factor: 29.690

4.  Hemodynamic effects of vasodilators and long-term response in heart failure.

Authors:  J A Franciosa; W B Dunkman; C L Leddy
Journal:  J Am Coll Cardiol       Date:  1984-06       Impact factor: 24.094

5.  Clinical assessment and follow-up of functional capacity in patients with chronic congestive cardiomyopathy.

Authors:  R Engler; R Ray; C B Higgins; C McNally; W H Buxton; V Bhargava; R Shabetai
Journal:  Am J Cardiol       Date:  1982-06       Impact factor: 2.778

6.  Digitalis-associated cardiac mortality after myocardial infarction.

Authors:  A J Moss; H T Davis; D L Conard; J J DeCamilla; C L Odoroff
Journal:  Circulation       Date:  1981-12       Impact factor: 29.690

7.  Maintenance digoxin after an episode of heart failure: placebo-controlled trial in outpatients.

Authors:  S M Dobbs; W I Kenyon; R J Dobbs
Journal:  Br Med J       Date:  1977-03-19

8.  Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Authors: 
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245

9.  How should we judge the efficacy of drug therapy in patients with chronic congestive heart failure? The insights of six blind men.

Authors:  M Packer
Journal:  J Am Coll Cardiol       Date:  1987-02       Impact factor: 24.094

10.  Is digoxin really important in treatment of compensated heart failure? A placebo-controlled crossover study in patients with sinus rhythm.

Authors:  J L Fleg; S H Gottlieb; E G Lakatta
Journal:  Am J Med       Date:  1982-08       Impact factor: 4.965

View more
  1 in total

Review 1.  Digitalis and heart failure: does digitalis really produce beneficial effects through a positive inotropic action?

Authors:  R Bolognesi; D Tsialtas; C Manca
Journal:  Cardiovasc Drugs Ther       Date:  1992-10       Impact factor: 3.727

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.